Meta-analysis of four phase III RCTs of tamoxifen, versus 3rd generation aromatase inhibitors as first-line endocrine therapy for HR+ advanced breast cancer von Robertson, J., Campbell, C., Bogaerts, J., Parideans, R., Lichfield, J.

Volltext

47PMeta-analysis of four phase III RCTs of tamoxifen, versus 3rd generation aromatase inhibitors as first-line endocrine therapy for HR+ advanced breast cancer von Robertson, J, Campbell, C, Bogaerts, J, Parideans, R, Lichfield, J

Volltext

Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: Ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepam von Cunningham, D., Dicato, M., Verweij, J., Crombez, R., de Mulder, P., du Bois, A., Stewart, A., Smyth, J., Selby, P., van Straelen, D., Parideans, R., McQuade, B., McRae, J.

Volltext

Preliminary Comparison between AQUA and Centralised ER/PgR Analysis within the TEAM Pathology Study von Bartlett, J., Rimm, D., Brookes, C., Dolled-Filhart, M., Robson, T., van de Velde, C., Billingham, L., Campbell, F., Hasenburg, A., Hille, E., Kieback, D., Putter, H., Markopoulos, C., Christiansen, J., Gustavson, M., Mallon, E., Meershoek-Klein Kranenburg, E., Parideans, R., Seynaeve, C., Rea, D.

Volltext

Oestrogen receptors in conjunctival malignant melanoma: immunocytochemical study using formalin fixed paraffin wax sections von Paridaens, D A, Alexander, R A, Hungerford, J L, McCartney, A C

Volltext